Defactinib-d6

• UNSPSC Description:

  Defactinib-d6 is a deuterium labeled Defactinib (HY-12289). Defactinib is a novel FAK inhibitor with potential antiangiogenic and antineoplastic activities[1].

• Target Antigen:

  FAK; Isotope-Labeled Compounds

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Others;Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(NC([2H])([2H])[2H])C1=CC=C(NC2=NC=C(C(F)(F)F)C(NCC3=NC=CN=C3N(C([2H])([2H])[2H])S(=O)(C)=O)=N2)C=C1

• Molecular Weight:

  516.53

• References & Citations:

  [1]Du W, et al. FAK inhibitor and combined medicine thereof. China, CN111377871A. 2020-07-07.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2384121-03-1